Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beta-Phellandrene SCHEMBL154149 | 1.00 | MET (0.31) | MET | |
| Beta-Phellandrene SCHEMBL17629433 | 1.00 | MET (0.31) | MET | |
| SCHEMBL25337903 | 0.86 | CYP3A4 (0.34) | MET | |
| SCHEMBL23268474 | 0.83 | — | — | |
| SCHEMBL10413490 | 0.82 | — | — | |
| Germacrene D SCHEMBL113144 | 0.82 | MET (0.47) | MET | |
| SCHEMBL11031845 | 0.82 | — | — | |
| SCHEMBL10412371 | 0.79 | — | — | |
| SCHEMBL10412372 | 0.79 | — | — | |
| Beta-Phellandrene SCHEMBL5011873 | 0.78 | MEN1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12233147-B2 | Method for treating keratin material | HENKEL AG & CO. KGAA (DE) | 2025-02-25 | — | — | US | disclosed |
| US-20240226034-A1 | Use of Terpenoids and Salicylates as Anesthetics and Analgesics | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-11 | — | — | US | disclosed |
| WO-2022232231-A1 | USE OF TERPENOIDS AND SALICYLATES AS ANESTHETICS, ANALGESICS, AND EUTHANASIA AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-11-03 | — | — | WO | disclosed |
| CN-108795773-B | Musk mould strain and perfume prepared from same | 贵州中烟工业有限责任公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20220211601-A1 | METHOD FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2022-07-07 | — | — | US | disclosed |
| EP-3946228-A1 | METHOD FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-02-09 | — | — | EP | disclosed |
| CN-113677314-A | Increasing the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2021-11-19 | — | — | CN | disclosed |
| WO-2020200574-A1 | METHOD FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2020-10-08 | — | — | WO | disclosed |
| US-8053587-B2 | for mounting onto a circuit board semiconductor devices | HENKEL CORPORATION (US) | 2011-11-08 | — | — | US | disclosed |
| US-20080214840-A1 | Reworkable thermosetting resin composition | HENKEL CORPORATION (US) | 2008-09-04 | — | — | US | disclosed |
| US-7012120-B2 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | HENKEL CORPORATION (US) | 2006-03-14 | — | — | US | disclosed |
| US-20050288458-A1 | Reworkable thermosetting resin composition | KLEMARCZYK PHILIP T | 2005-12-29 | — | — | US | disclosed |
| US-20030073770-A1 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | Henkel IP & Holding GmbH (DE) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12233147-B2 | Method for treating keratin material | KRT18, CCNA1, CCNT1 | MET 2310/4885 |
| US-20220211601-A1 | METHOD FOR TREATING KERATIN MATERIAL | KRT18, CCNA1, CCNT1 | MET 2310/4885 |
| US-20080214840-A1 | Reworkable thermosetting resin composition | GSS, LSS, LRBA | MET 4874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.